期刊文献+

15例异基因造血干细胞移植术后复发患者骨髓中树突细胞亚群分析

原文传递
导出
摘要 近年来,人们将供者淋巴细胞输注(DLI)用于白血病患者异基因造血干细胞移植(allo—HSCT)术后复发的治疗,并获得良好效果。许多临床研究结果显示,无论是allo-HSCT治疗白血病还是DLI治疗allo—HSCT术后复发均存在一个规律:即对慢性粒细胞白血病慢性期(CML-CP)效果最好,急性髓系白血病(AML)其次,急性淋巴细胞白血病(ALL)最差。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第5期339-341,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献5

二级参考文献28

  • 1Schleuning M. Adoptive allogeneic immunotherapy-history and future perspectives. Transfusion Sci, 2000, 3: 133-150.
  • 2Kolb HK, Schmid C, Barrett A J, et al. Graft- versus-leukemia reactions in allogeneic chimeras. Blood, 2004, 103: 767-776.
  • 3Slavin S. Graft-versus-host disease, the graft-versus-leukemia effect,and mixed chimerism following nonmyeloablative stem cell transplantation. Int J Hematol, 2003, 78: 195-207.
  • 4Bethge WA, Hegenbart U, Stuart JM, et al. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Blood, 2004,103: 790-795.
  • 5Guglielmi C, Arcese W, Dazzi F, et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood, 2002, 100: 397-405.
  • 6Dazzi F, Szydlo RM, Craddock C, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood, 2000, 95: 67-71.
  • 7Billiau AD, Fevery S, Rutgeerts O, et al. Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Blood, 2002, 100: 1894-1902.
  • 8Nadal E, Fowler A, Kanfer E, et al. Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions. Exp Hematol,2004, 32: 218-223.
  • 9Leda M, Ladon D, Pieczonka A, et al. Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res, 2001, 25: 353-357.
  • 10Posthuma EF, Marijt EW, Barge RM, et al. alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versushost disease. Biol Blood Marrow Transplant, 2004, 10:204-212.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部